APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacology Discovery Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacology Discovery Service Market Outlook and Growth Opportunities 2026

3 May 2026192 pages

Choose your research edition.

Industry ResearchPharmacology Discovery Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacology Discovery Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmacology Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacology Discovery Service Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacology Discovery Service Market Analysis and Forecast 2026-2032253 pages · $4,950 USD

Market perspective

The global Pharmacology Discovery Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacology Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacology Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacology Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacology Discovery Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacology Discovery Service market include Ichor Life Sciences, Inc, NUVISAN, Porsolt, Charles River Laboratories, Eurofins Discovery, Labcorp, BioDuro-Sundia, Creative Biolabs and BRF, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacology Discovery Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacology Discovery Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacology Discovery Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacology Discovery Service market.

Pharmacology Discovery Service Segment by Company

Ichor Life Sciences, Inc

NUVISAN

Porsolt

Charles River Laboratories

Eurofins Discovery

Labcorp

BioDuro-Sundia

Creative Biolabs

BRF

WuXi AppTec

Dalriada

Sygnature Discovery

Pharmaron

ChemPartner

NuChem Sciences Inc

Genscript ProBio

Pharmacology Discovery Service Segment by Type

In Vivo Disease Model

Cell Based Assays Service

Drug Discovery Service

Others

Pharmacology Discovery Service Segment by Application

Cardiovascular Disease

Eye Diseases

Autoimmune Diseases

Musculoskeletal Diseases

Other

Pharmacology Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacology Discovery Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacology Discovery Service key companies, revenue, market share, and recent developments.

3. To split the Pharmacology Discovery Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacology Discovery Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacology Discovery Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacology Discovery Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacology Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacology Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacology Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacology Discovery Service industry.

Chapter 3: Detailed analysis of Pharmacology Discovery Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacology Discovery Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacology Discovery Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacology Discovery Service Industry Trends Table 2. Pharmacology Discovery Service Industry Drivers Table 3. Pharmacology Discovery Service Industry Opportunities and Challenges Table 4. Pharmacology Discovery Service Industry Restraints Table 5. Global Pharmacology Discovery Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacology Discovery Service Revenue Share by Company (2021-2026) Table 7. Global Pharmacology Discovery Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacology Discovery Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacology Discovery Service Company, Product Type & Application Table 10. Global Pharmacology Discovery Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacology Discovery Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vivo Disease Model Table 15. Significant Companies of Cell Based Assays Service Table 16. Significant Companies of Drug Discovery Service Table 17. Significant Companies of Others Table 18. Global Pharmacology Discovery Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmacology Discovery Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmacology Discovery Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmacology Discovery Service Sales Value Share by Type (2021-2026) Table 22. Global Pharmacology Discovery Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Cardiovascular Disease Table 24. Significant Companies of Eye Diseases Table 25. Significant Companies of Autoimmune Diseases Table 26. Significant Companies of Musculoskeletal Diseases Table 27. Significant Companies of Other Table 28. Global Pharmacology Discovery Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pharmacology Discovery Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Pharmacology Discovery Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Pharmacology Discovery Service Sales Value Share by Application (2021-2026) Table 32. Global Pharmacology Discovery Service Sales Value Share by Application (2027-2032) Table 33. Global Pharmacology Discovery Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pharmacology Discovery Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Pharmacology Discovery Service Sales Value Share by Region (2021-2026) Table 36. Global Pharmacology Discovery Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Pharmacology Discovery Service Sales Value Share by Region (2027-2032) Table 38. Global Pharmacology Discovery Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharmacology Discovery Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Pharmacology Discovery Service Sales Value Market Share by Country (2021-2026) Table 41. Global Pharmacology Discovery Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Pharmacology Discovery Service Sales Value Market Share by Country (2027-2032) Table 43. Ichor Life Sciences, Inc Company Information Table 44. Ichor Life Sciences, Inc Business Overview Table 45. Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Ichor Life Sciences, Inc Pharmacology Discovery Service Product Portfolio Table 47. Ichor Life Sciences, Inc Recent Development Table 48. NUVISAN Company Information Table 49. NUVISAN Business Overview Table 50. NUVISAN Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. NUVISAN Pharmacology Discovery Service Product Portfolio Table 52. NUVISAN Recent Development Table 53. Porsolt Company Information Table 54. Porsolt Business Overview Table 55. Porsolt Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Porsolt Pharmacology Discovery Service Product Portfolio Table 57. Porsolt Recent Development Table 58. Charles River Laboratories Company Information Table 59. Charles River Laboratories Business Overview Table 60. Charles River Laboratories Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Charles River Laboratories Pharmacology Discovery Service Product Portfolio Table 62. Charles River Laboratories Recent Development Table 63. Eurofins Discovery Company Information Table 64. Eurofins Discovery Business Overview Table 65. Eurofins Discovery Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Eurofins Discovery Pharmacology Discovery Service Product Portfolio Table 67. Eurofins Discovery Recent Development Table 68. Labcorp Company Information Table 69. Labcorp Business Overview Table 70. Labcorp Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Labcorp Pharmacology Discovery Service Product Portfolio Table 72. Labcorp Recent Development Table 73. BioDuro-Sundia Company Information Table 74. BioDuro-Sundia Business Overview Table 75. BioDuro-Sundia Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BioDuro-Sundia Pharmacology Discovery Service Product Portfolio Table 77. BioDuro-Sundia Recent Development Table 78. Creative Biolabs Company Information Table 79. Creative Biolabs Business Overview Table 80. Creative Biolabs Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Creative Biolabs Pharmacology Discovery Service Product Portfolio Table 82. Creative Biolabs Recent Development Table 83. BRF Company Information Table 84. BRF Business Overview Table 85. BRF Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BRF Pharmacology Discovery Service Product Portfolio Table 87. BRF Recent Development Table 88. WuXi AppTec Company Information Table 89. WuXi AppTec Business Overview Table 90. WuXi AppTec Pharmacology Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. WuXi AppTec Pharmacology Discovery Service Product Portfolio Table 92. WuXi AppTec Recent Development Table 93. Dalriada Company Information Table 94. Dalriada Business Overview Table 95. Dalriada Pharmacology Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Dalriada Pharmacology Discovery Service Product Portfolio Table 97. Dalriada Recent Development Table 98. Sygnature Discovery Company Information Table 99. Sygnature Discovery Business Overview Table 100. Sygnature Discovery Pharmacology Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Sygnature Discovery Pharmacology Discovery Service Product Portfolio Table 102. Sygnature Discovery Recent Development Table 103. Pharmaron Company Information Table 104. Pharmaron Business Overview Table 105. Pharmaron Pharmacology Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Pharmaron Pharmacology Discovery Service Product Portfolio Table 107. Pharmaron Recent Development Table 108. ChemPartner Company Information Table 109. ChemPartner Business Overview Table 110. ChemPartner Pharmacology Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. ChemPartner Pharmacology Discovery Service Product Portfolio Table 112. ChemPartner Recent Development Table 113. NuChem Sciences Inc Company Information Table 114. NuChem Sciences Inc Business Overview Table 115. NuChem Sciences Inc Pharmacology Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. NuChem Sciences Inc Pharmacology Discovery Service Product Portfolio Table 117. NuChem Sciences Inc Recent Development Table 118. Genscript ProBio Company Information Table 119. Genscript ProBio Business Overview Table 120. Genscript ProBio Pharmacology Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Genscript ProBio Pharmacology Discovery Service Product Portfolio Table 122. Genscript ProBio Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Pharmacology Discovery Service Product Image Figure 2. Global Pharmacology Discovery Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacology Discovery Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacology Discovery Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vivo Disease Model Image Figure 8. Cell Based Assays Service Image Figure 9. Drug Discovery Service Image Figure 10. Others Image Figure 11. Global Pharmacology Discovery Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmacology Discovery Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmacology Discovery Service Sales Value Share by Type (2021-2032) Figure 14. Cardiovascular Disease Image Figure 15. Eye Diseases Image Figure 16. Autoimmune Diseases Image Figure 17. Musculoskeletal Diseases Image Figure 18. Other Image Figure 19. Global Pharmacology Discovery Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmacology Discovery Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Pharmacology Discovery Service Sales Value Share by Application (2021-2032) Figure 22. Global Pharmacology Discovery Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Pharmacology Discovery Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Pharmacology Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Pharmacology Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Pharmacology Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Pharmacology Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Pharmacology Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Pharmacology Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Pharmacology Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Pharmacology Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Pharmacology Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Pharmacology Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Pharmacology Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo Disease Model
  • Cell Based Assays Service
  • Drug Discovery Service
  • Others
Applications
  • Cardiovascular Disease
  • Eye Diseases
  • Autoimmune Diseases
  • Musculoskeletal Diseases
  • Other
Companies covered
  • Ichor Life Sciences, Inc
  • NUVISAN
  • Porsolt
  • Charles River Laboratories
  • Eurofins Discovery
  • Labcorp
  • BioDuro-Sundia
  • Creative Biolabs
  • BRF
  • WuXi AppTec
  • Dalriada
  • Sygnature Discovery
  • Pharmaron
  • ChemPartner
  • NuChem Sciences Inc
  • Genscript ProBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacology Discovery Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacology Discovery Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacology Discovery Service Market Dynamics
  1. 2.1 Pharmacology Discovery Service Industry Trends
  2. 2.2 Pharmacology Discovery Service Industry Drivers
  3. 2.3 Pharmacology Discovery Service Industry Opportunities and Challenges
  4. 2.4 Pharmacology Discovery Service Industry Restraints
3 Pharmacology Discovery Service Market by Company
  1. 3.1 Global Pharmacology Discovery Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacology Discovery Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacology Discovery Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmacology Discovery Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacology Discovery Service Company Product Type and Application
  6. 3.6 Global Pharmacology Discovery Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacology Discovery Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacology Discovery Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacology Discovery Service Market by Type
  1. 4.1 Pharmacology Discovery Service Type Introduction
  2. 4.1.1 In Vivo Disease Model
  3. 4.1.2 Cell Based Assays Service
  4. 4.1.3 Drug Discovery Service
  5. 4.1.4 Others
  6. 4.2 Global Pharmacology Discovery Service Sales Value by Type
  7. 4.2.1 Global Pharmacology Discovery Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmacology Discovery Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmacology Discovery Service Sales Value Share by Type (2021-2032)
5 Pharmacology Discovery Service Market by Application
  1. 5.1 Pharmacology Discovery Service Application Introduction
  2. 5.1.1 Cardiovascular Disease
  3. 5.1.2 Eye Diseases
  4. 5.1.3 Autoimmune Diseases
  5. 5.1.4 Musculoskeletal Diseases
  6. 5.1.5 Other
  7. 5.2 Global Pharmacology Discovery Service Sales Value by Application
  8. 5.2.1 Global Pharmacology Discovery Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pharmacology Discovery Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Pharmacology Discovery Service Sales Value Share by Application (2021-2032)
6 Pharmacology Discovery Service Regional Value Analysis
  1. 6.1 Global Pharmacology Discovery Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacology Discovery Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacology Discovery Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacology Discovery Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacology Discovery Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacology Discovery Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacology Discovery Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacology Discovery Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacology Discovery Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacology Discovery Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacology Discovery Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacology Discovery Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacology Discovery Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacology Discovery Service Sales Value Share by Country, 2025 VS 2032
7 Pharmacology Discovery Service Country-level Value Analysis
  1. 7.1 Global Pharmacology Discovery Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacology Discovery Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacology Discovery Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacology Discovery Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacology Discovery Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacology Discovery Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacology Discovery Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ichor Life Sciences, Inc
  2. 8.1.1 Ichor Life Sciences, Inc Company Information
  3. 8.1.2 Ichor Life Sciences, Inc Business Overview
  4. 8.1.3 Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ichor Life Sciences, Inc Pharmacology Discovery Service Product Portfolio
  6. 8.1.5 Ichor Life Sciences, Inc Recent Developments
  7. 8.2 NUVISAN
  8. 8.2.1 NUVISAN Company Information
  9. 8.2.2 NUVISAN Business Overview
  10. 8.2.3 NUVISAN Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NUVISAN Pharmacology Discovery Service Product Portfolio
  12. 8.2.5 NUVISAN Recent Developments
  13. 8.3 Porsolt
  14. 8.3.1 Porsolt Company Information
  15. 8.3.2 Porsolt Business Overview
  16. 8.3.3 Porsolt Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Porsolt Pharmacology Discovery Service Product Portfolio
  18. 8.3.5 Porsolt Recent Developments
  19. 8.4 Charles River Laboratories
  20. 8.4.1 Charles River Laboratories Company Information
  21. 8.4.2 Charles River Laboratories Business Overview
  22. 8.4.3 Charles River Laboratories Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Laboratories Pharmacology Discovery Service Product Portfolio
  24. 8.4.5 Charles River Laboratories Recent Developments
  25. 8.5 Eurofins Discovery
  26. 8.5.1 Eurofins Discovery Company Information
  27. 8.5.2 Eurofins Discovery Business Overview
  28. 8.5.3 Eurofins Discovery Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Discovery Pharmacology Discovery Service Product Portfolio
  30. 8.5.5 Eurofins Discovery Recent Developments
  31. 8.6 Labcorp
  32. 8.6.1 Labcorp Company Information
  33. 8.6.2 Labcorp Business Overview
  34. 8.6.3 Labcorp Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Pharmacology Discovery Service Product Portfolio
  36. 8.6.5 Labcorp Recent Developments
  37. 8.7 BioDuro-Sundia
  38. 8.7.1 BioDuro-Sundia Company Information
  39. 8.7.2 BioDuro-Sundia Business Overview
  40. 8.7.3 BioDuro-Sundia Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BioDuro-Sundia Pharmacology Discovery Service Product Portfolio
  42. 8.7.5 BioDuro-Sundia Recent Developments
  43. 8.8 Creative Biolabs
  44. 8.8.1 Creative Biolabs Company Information
  45. 8.8.2 Creative Biolabs Business Overview
  46. 8.8.3 Creative Biolabs Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Creative Biolabs Pharmacology Discovery Service Product Portfolio
  48. 8.8.5 Creative Biolabs Recent Developments
  49. 8.9 BRF
  50. 8.9.1 BRF Company Information
  51. 8.9.2 BRF Business Overview
  52. 8.9.3 BRF Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BRF Pharmacology Discovery Service Product Portfolio
  54. 8.9.5 BRF Recent Developments
  55. 8.10 WuXi AppTec
  56. 8.10.1 WuXi AppTec Company Information
  57. 8.10.2 WuXi AppTec Business Overview
  58. 8.10.3 WuXi AppTec Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 WuXi AppTec Pharmacology Discovery Service Product Portfolio
  60. 8.10.5 WuXi AppTec Recent Developments
  61. 8.11 Dalriada
  62. 8.11.1 Dalriada Company Information
  63. 8.11.2 Dalriada Business Overview
  64. 8.11.3 Dalriada Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dalriada Pharmacology Discovery Service Product Portfolio
  66. 8.11.5 Dalriada Recent Developments
  67. 8.12 Sygnature Discovery
  68. 8.12.1 Sygnature Discovery Company Information
  69. 8.12.2 Sygnature Discovery Business Overview
  70. 8.12.3 Sygnature Discovery Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sygnature Discovery Pharmacology Discovery Service Product Portfolio
  72. 8.12.5 Sygnature Discovery Recent Developments
  73. 8.13 Pharmaron
  74. 8.13.1 Pharmaron Company Information
  75. 8.13.2 Pharmaron Business Overview
  76. 8.13.3 Pharmaron Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pharmaron Pharmacology Discovery Service Product Portfolio
  78. 8.13.5 Pharmaron Recent Developments
  79. 8.14 ChemPartner
  80. 8.14.1 ChemPartner Company Information
  81. 8.14.2 ChemPartner Business Overview
  82. 8.14.3 ChemPartner Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ChemPartner Pharmacology Discovery Service Product Portfolio
  84. 8.14.5 ChemPartner Recent Developments
  85. 8.15 NuChem Sciences Inc
  86. 8.15.1 NuChem Sciences Inc Company Information
  87. 8.15.2 NuChem Sciences Inc Business Overview
  88. 8.15.3 NuChem Sciences Inc Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 NuChem Sciences Inc Pharmacology Discovery Service Product Portfolio
  90. 8.15.5 NuChem Sciences Inc Recent Developments
  91. 8.16 Genscript ProBio
  92. 8.16.1 Genscript ProBio Company Information
  93. 8.16.2 Genscript ProBio Business Overview
  94. 8.16.3 Genscript ProBio Pharmacology Discovery Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Genscript ProBio Pharmacology Discovery Service Product Portfolio
  96. 8.16.5 Genscript ProBio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst